| human | Q5 |
| P496 | ORCID iD | 0000-0002-9400-5309 |
| P735 | given name | Deborah | Q18558974 |
| Deborah | Q18558974 | ||
| P106 | occupation | researcher | Q1650915 |
| Q108899726 | 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro |
| Q97426440 | 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities |
| Q34261516 | A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses |
| Q44973880 | Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis |
| Q38614093 | Antiviral Properties of ISG15. |
| Q36114846 | Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis |
| Q35946144 | Chikungunya virus-induced autophagy delays caspase-dependent cell death |
| Q28599242 | Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen |
| Q40279449 | Chikungunya-induced cell death is limited by ER and oxidative stress-induced autophagy |
| Q104757295 | Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease |
| Q42091648 | Cutting edge: paradoxical roles of BST2/tetherin in promoting type I IFN response and viral infection |
| Q92982929 | Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA |
| Q90753661 | Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation |
| Q37404247 | Emerging roles for immunomodulatory functions of free ISG15. |
| Q35233593 | Human cytomegalovirus pUL79 is an elongation factor of RNA polymerase II for viral gene transcription |
| Q28507005 | IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses |
| Q27865223 | ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus |
| Q27317417 | ISG15 deficiency and increased viral resistance in humans but not mice |
| Q38988141 | ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle |
| Q88701533 | ISG15 in antiviral immunity and beyond |
| Q34058142 | ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation |
| Q28593490 | Identification of a candidate therapeutic autophagy-inducing peptide |
| Q24537289 | Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo |
| Q35880553 | Increased cerebral protein ISGylation after focal ischemia is neuroprotective |
| Q34391631 | Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus |
| Q91196291 | Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death |
| Q47549786 | Lessons learned from Chikungunya in the Americas |
| Q41893512 | Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection |
| Q96585271 | Modulation of Extracellular ISG15 Signaling by Pathogens and Viral Effector Proteins |
| Q39964102 | Nitrosylation of ISG15 prevents the disulfide bond-mediated dimerization of ISG15 and contributes to effective ISGylation |
| Q34992604 | Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice |
| Q34725292 | Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses |
| Q48434755 | Pillars article: CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1994. 1: 405-413. |
| Q34499531 | Polymyalgia rheumatica/temporal arteritis: recent advances |
| Q27863897 | Proteomic identification of proteins conjugated to ISG15 in mouse and human cells |
| Q28387786 | Replication-competent fluorescent-expressing influenza B virus |
| Q39068689 | Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor |
| Q34458906 | Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance |
| Q27865245 | Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein |
| Q38149665 | The antiviral activities of ISG15. |
| Q39021236 | The impact of ISGylation during Mycobacterium tuberculosis infection in mice. |
| Q40107499 | The microbial metabolite desaminotyrosine protects from influenza through type I interferon. |
| Q28656412 | Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis |
| Q34978471 | Type I interferons link viral infection to enhanced epithelial turnover and repair. |
Search more.